Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III.

Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III. Abstract Text:

Scott C Howard,Judy A Wilimas,Andronica Flores,C Pacheco,Gladis de Reyes,Sergio Machin,Eva Svarch,Marta Navarrete,Rosa Nieves,Hilze Rodriguez,Giuseppe Masera, ,

Treatment of hematologic disorders in low-income countries (LIC) is difficult. This report summarizes treatment of sickle cell disease and aplastic anemia by pediatric hematologists from 15 LIC who participate in the Monza International School of Pediatric Hematology/Oncology (MISPHO). Patients with severe sickle cell disease were treated with low dose hydroxyurea, which safely reduced vaso-occlusive crises. Patients with severe aplastic anemia fared poorly due to lack of availability and high cost of anti-thymocyte globulin and cyclosporine and lack of access to stem cell transplantation. Appropriate therapy was most likely to occur in MISPHO centers with an active twinning program with a center in a high-income country.

Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III. Publishing Authors By Initials

SC Howard,JA Wilimas,A Flores,C Pacheco,G de Reyes,S Machin,E Svarch,M Navarrete,R Nieves,H Rodriguez,G Masera, ,

For similar geographic locations: americas: latin america research abstracts see: geographic locations: americas: latin america research

PUBMED ID PMID:

MEDLINE DATE:

Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Pediatric blood & cancer

VOLUME: 48

Page Numbers: 598-9

Journal Abbreviation:

ISSN: 1545-5009

DAY: 3

MONTH: May

YEAR: 2007

Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101186624

Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III. Keywords Mesh Terms:

KEYWORDS: Latin America

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III. Information

Substance Name: Cyclosporine

Registry Number: 59865-13-3

Grant and Affiliation Information for Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III.

AFFILIATION: International Outreach Program and Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. Scott.howard@stjude.org

Country: United States

AGENCY: United States NCI

GRANT: CA-21765

ACRONYM: CA

MEDLINETA: Pediatr Blood Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology MISPHO: Part III Related Publications

• A device to perform Percutaneous Cervical Pharyngostomy (PCP) for Enteral Nutrition.
• Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I.
• Income matters: reducing the mortality gap.
• Reduction in personal exposures to particulate matter and carbon monoxide as a result of the installation of a Patsari improved cook stove in Michoacan Mexico.
• Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III.
• [Not Available.]